Logo image of IBG

INNOVATION BEVERAGE GROUP LT (IBG) Stock Fundamental Analysis

NASDAQ:IBG - Nasdaq - AU0000226177 - Common Stock - Currency: USD

0.59  +0.01 (+0.85%)

After market: 0.6399 +0.05 (+8.46%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to IBG. IBG was compared to 32 industry peers in the Beverages industry. Both the profitability and financial health of IBG have multiple concerns. IBG is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year IBG has reported negative net income.
IBG had a negative operating cash flow in the past year.
IBG Yearly Net Income VS EBIT VS OCF VS FCFIBG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -1M -2M -3M -4M

1.2 Ratios

IBG has a worse Return On Assets (-97.18%) than 93.75% of its industry peers.
IBG has a Return On Equity of -183.88%. This is amonst the worse of the industry: IBG underperforms 87.50% of its industry peers.
Industry RankSector Rank
ROA -97.18%
ROE -183.88%
ROIC N/A
ROA(3y)-60.99%
ROA(5y)N/A
ROE(3y)-591.24%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IBG Yearly ROA, ROE, ROICIBG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

IBG's Gross Margin of 58.09% is amongst the best of the industry. IBG outperforms 81.25% of its industry peers.
IBG's Gross Margin has improved in the last couple of years.
IBG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.62%
GM growth 5YN/A
IBG Yearly Profit, Operating, Gross MarginsIBG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50

More info and screens

3

2. Health

2.1 Basic Checks

IBG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IBG has less shares outstanding
Compared to 1 year ago, IBG has an improved debt to assets ratio.
IBG Yearly Shares OutstandingIBG Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M 10M
IBG Yearly Total Debt VS Total AssetsIBG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

Based on the Altman-Z score of -2.44, we must say that IBG is in the distress zone and has some risk of bankruptcy.
IBG has a Altman-Z score of -2.44. This is in the lower half of the industry: IBG underperforms 78.13% of its industry peers.
IBG has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
IBG has a better Debt to Equity ratio (0.16) than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z -2.44
ROIC/WACCN/A
WACC8.44%
IBG Yearly LT Debt VS Equity VS FCFIBG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M

2.3 Liquidity

A Current Ratio of 1.14 indicates that IBG should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.14, IBG is in line with its industry, outperforming 43.75% of the companies in the same industry.
IBG has a Quick Ratio of 1.14. This is a bad value and indicates that IBG is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of IBG (0.65) is worse than 65.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.65
IBG Yearly Current Assets VS Current LiabilitesIBG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 1M 2M 3M 4M

More info and screens

4

3. Growth

3.1 Past

IBG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -54.16%.
Looking at the last year, IBG shows a decrease in Revenue. The Revenue has decreased by -6.88% in the last year.
IBG shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.87% yearly.
EPS 1Y (TTM)-54.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.23%
Revenue 1Y (TTM)-6.88%
Revenue growth 3Y-7.87%
Revenue growth 5YN/A
Sales Q2Q%-30.52%

3.2 Future

Based on estimates for the next years, IBG will show a very strong growth in Earnings Per Share. The EPS will grow by 35.53% on average per year.
The Revenue is expected to grow by 43.78% on average over the next years. This is a very strong growth
EPS Next Y47.82%
EPS Next 2Y35.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year55.06%
Revenue Next 2Y43.79%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IBG Yearly Revenue VS EstimatesIBG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2M 4M 6M
IBG Yearly EPS VS EstimatesIBG Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 -0.05 -0.1 -0.15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

IBG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IBG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IBG Price Earnings VS Forward Price EarningsIBG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IBG Per share dataIBG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6

4.3 Compensation for Growth

A more expensive valuation may be justified as IBG's earnings are expected to grow with 35.53% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.53%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

IBG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INNOVATION BEVERAGE GROUP LT

NASDAQ:IBG (7/11/2025, 8:22:16 PM)

After market: 0.6399 +0.05 (+8.46%)

0.59

+0.01 (+0.85%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners7.85%
Inst Owner ChangeN/A
Ins Owners17.24%
Ins Owner ChangeN/A
Market Cap5.48M
Analysts80
Price Target4.08 (591.53%)
Short Float %0.88%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.89
P/FCF N/A
P/OCF N/A
P/B 2.09
P/tB 2.4
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS0.66
BVpS0.28
TBVpS0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -97.18%
ROE -183.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 58.09%
FCFM N/A
ROA(3y)-60.99%
ROA(5y)N/A
ROE(3y)-591.24%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.62%
GM growth 5YN/A
F-Score5
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.07%
Cap/Sales 0.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.65
Altman-Z -2.44
F-Score5
WACC8.44%
ROIC/WACCN/A
Cap/Depr(3y)5.82%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.37%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-54.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.23%
EPS Next Y47.82%
EPS Next 2Y35.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.88%
Revenue growth 3Y-7.87%
Revenue growth 5YN/A
Sales Q2Q%-30.52%
Revenue Next Year55.06%
Revenue Next 2Y43.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-20.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year56.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0%
OCF growth 3YN/A
OCF growth 5YN/A